Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-052671
Filing Date
2021-10-13
Accepted
2021-10-13 17:25:13
Documents
1
Period of Report
2021-10-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5721
  Complete submission text file 0001213900-21-052671.txt   7282
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Czuczman Myron (Reporting) CIK: 0001817716 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 211321949